Aptevo Therapeutics, Inc. (APVO)
Aptevo Therapeutics Market Cap : 1.080M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.080M |
| November 19, 2026 | 1.106M |
| November 18, 2026 | 1.192M |
| November 17, 2026 | 1.232M |
| November 16, 2026 | 1.466M |
| November 13, 2026 | 1.587M |
| November 12, 2026 | 1.764M |
| November 11, 2026 | 1.078M |
| November 10, 2026 | 1.532M |
| November 09, 2026 | 1.604M |
| November 06, 2026 | 1.760M |
| November 05, 2026 | 1.802M |
| November 04, 2026 | 1.944M |
| November 03, 2026 | 1.930M |
| November 02, 2026 | 1.916M |
| October 30, 2026 | 1.902M |
| October 29, 2026 | 1.930M |
| October 28, 2026 | 1.845M |
| October 27, 2026 | 1.816M |
| October 26, 2026 | 2.128M |
| October 23, 2026 | 2.285M |
| October 22, 2026 | 2.285M |
| October 21, 2026 | 2.270M |
| October 20, 2026 | 2.292M |
| October 19, 2026 | 2.270M |
| Date | Value |
|---|---|
| October 16, 2026 | 2.299M |
| October 15, 2026 | 2.412M |
| October 14, 2026 | 2.455M |
| October 13, 2026 | 2.455M |
| October 12, 2026 | 2.606M |
| October 09, 2026 | 2.54M |
| October 08, 2026 | 2.554M |
| October 07, 2026 | 2.611M |
| October 06, 2026 | 2.547M |
| October 05, 2026 | 2.554M |
| October 02, 2026 | 2.497M |
| October 01, 2026 | 2.497M |
| September 30, 2026 | 2.583M |
| September 29, 2026 | 2.639M |
| September 28, 2026 | 2.710M |
| September 25, 2026 | 2.682M |
| September 24, 2026 | 2.597M |
| September 23, 2026 | 2.682M |
| September 22, 2026 | 2.625M |
| September 21, 2026 | 2.568M |
| September 18, 2026 | 2.611M |
| September 17, 2026 | 2.611M |
| September 16, 2026 | 2.441M |
| September 15, 2026 | 2.426M |
| September 14, 2026 | 2.554M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 46.29M |
| Sangamo Therapeutics, Inc. | 43.91M |
| Sarepta Therapeutics, Inc. | 1.429B |
| Anixa Biosciences, Inc. | 84.39M |
| Vicapsys Life Sciences, Inc. | 16.19M |
Market Cap Related Metrics
| Price to Book Value | 0.2796 |
| Price | 0.4041 |
| Earnings Yield | -5.65K% |